Pfizer’s Maternal RSV Vaccine First to Win FDA Panel Support
Pfizer Inc.’s vaccine to protect newborns from RSV received backing from US regulatory advisers for use in pregnant mothers to protect their newborns, handing the drugmaker a win in the race to dominate immunization against the virus.








